source
- Experts outline PET-CT, biopsy and mutation testing to guide therapy in relapsed CLLIn a recent discussion, clinicians described the workup for patients with progressive chronic lymphocytic leukemia (CLL). They emphasized using PET‑CT imaging and excisional lymph node biopsy when…
- Experts discuss mutation testing and patient factors to guide second-line CLL therapy after BTK inhibitor resistanceA 66-year-old man who was diagnosed with chronic lymphocytic leukemia five years ago and initially had an unmutated IGHV profile without TP53 alteration has been on continuous covalent BTK inhibito…